Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

187.20
BATS BZX Real-Time Price
As of 12:37pm ET
 +3.48 / +1.89%
Today’s Change
151.80
Today|||52-Week Range
195.81
+12.97%
Year-to-Date

Today’s Trading

Previous close183.72
Today’s open185.15
Day’s range184.60 - 187.26
Volume194,537
Average volume (3 months)1,211,706
Market cap$47.6B
Data as of 12:37pm ET, 08/21/2019

Growth & Valuation

Earnings growth (last year)+677.36%
Earnings growth (this year)+12.28%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+22.51%
P/E ratio21.9
Price/Sales14.09
Price/Book10.65

Competitors

 Today’s
change
Today’s
% change
AGNAllergan+1.77+1.11%
TAKTakeda Pharmaceutica...-0.22-1.31%
ZTSZoetis Inc+1.63+1.29%
REGNRegeneron Pharmaceut...-0.07-0.02%
Data as of 12:38pm ET, 08/21/2019

Financials

Next reporting dateOctober 23, 2019
EPS forecast (this quarter)$1.13
Annual revenue (last year)$3.0B
Annual profit (last year)$2.1B
Net profit margin68.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Financial Officer &
Executive Vice President
Charles F. Wagner
Corporate headquarters
Boston, Massachusetts

Forecasts